tiprankstipranks
Trending News
More News >
Mangoceuticals, Inc. (MGRX)
NASDAQ:MGRX
US Market

Mangoceuticals, Inc. (MGRX) Income Statement

Compare
125 Followers

Mangoceuticals, Inc. Income Statement

Last quarter (Q3 2025), Mangoceuticals, Inc.'s total revenue was $84.25K, a decrease of -36.83% from the same quarter last year. In Q3, Mangoceuticals, Inc.'s net income was $-7.62M. See Mangoceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 615.87K$ 731.49K$ 8.94K$ 0.00
Gross Profit
$ 379.96K$ 431.50K$ 4.85K$ 0.00
Operating Expenses
$ 8.35M$ 9.65M$ 2.00M$ 17.52K
Depreciation and Amortization
$ 721.53K$ 24.89K$ 3.86K$ 0.00
EBITDA
$ -7.96M$ -8.09M$ -1.99M$ -17.52K
Operating Income
$ -7.97M$ -9.22M$ -1.99M$ -17.52K
Other Income/Expenses
$ -735.00K$ 6.47K$ -6.47K$ -181.00
Pretax Income
$ -8.71M$ -9.21M$ -2.00M$ -17.70K
Net Income
$ -8.71M$ -9.21M$ -2.00M$ -17.70K
Per Share Metrics
Basic EPS
$ -4.40$ -8.58$ -1.73$ -0.02
Diluted EPS
$ -4.40$ -8.58$ -1.73$ -0.02
Weighted Average Shares Outstanding
1.98M 1.07M 1.15M 997.67K
Weighted Average Shares Outstanding (Diluted)
1.98M 1.07M 1.15M 997.67K
Currency in USD

Mangoceuticals, Inc. Earnings and Revenue History